Post-earnings recap
Reported
Thu, Jan 23, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report showed a slight miss on EPS, which typically indicates challenges in profitability. However, the stock still reacted positively, gaining 0.77%, suggesting that investors may have had lower expectations or are optimistic about future performance despite the EPS miss.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.60 | N/A | -4.76% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.